Exact Mass: 1015.5966912
Exact Mass Matches: 1015.5966912
Found 37 metabolites which its exact mass value is equals to given mass value 1015.5966912
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
cyclo(-Val-Ile-Pro-Ala-Val-Ile-Pro-Tyr-Tyr-)|dichotomin K
cyclo(-Phe-Pro-Pro-Pro-Phe-Phe-Val-Ile-Ala-)|drymarin A
C56H73N9O9 (1015.5530967999999)
[1-[18-Benzyl-3-(1-methoxyethyl)-4,9,10,12,16-pentamethyl-15-methylidene-2,5,8,11,14,17,20-heptaoxo-21-(propanoylamino)-22-propan-2-yl-1,19-dioxa-4,7,10,13,16-pentazacyclodocos-6-yl]-2-methylpropyl] 3-hydroxy-4-methyl-2-(propanoylamino)pentanoate
(11Z,14Z,17Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetradeca-4,8-dien-2-yl]icosa-11,14,17-trienamide
C52H89NO18 (1015.6079334000001)
(8Z,11Z,14Z,17Z)-N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetradec-4-en-2-yl]icosa-8,11,14,17-tetraenamide
C52H89NO18 (1015.6079334000001)
(14Z,17Z,20Z,23Z)-N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]hexacosa-14,17,20,23-tetraenamide
C52H89NO18 (1015.6079334000001)
(9Z,12Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxypentadeca-4,8,12-trien-2-yl]nonadeca-9,12-dienamide
C52H89NO18 (1015.6079334000001)
(11Z,14Z,17Z,20Z,23Z)-N-[1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyoctan-2-yl]hexacosa-11,14,17,20,23-pentaenamide
C52H89NO18 (1015.6079334000001)
(11Z,14Z)-N-[(4E,8E,12E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetradeca-4,8,12-trien-2-yl]icosa-11,14-dienamide
C52H89NO18 (1015.6079334000001)
(9Z,12Z,15Z,18Z,21Z)-N-[1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxydecan-2-yl]tetracosa-9,12,15,18,21-pentaenamide
C52H89NO18 (1015.6079334000001)
(3Z,6Z,9Z,12Z,15Z)-N-[1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxyhexadecan-2-yl]octadeca-3,6,9,12,15-pentaenamide
C52H89NO18 (1015.6079334000001)
(10Z,13Z,16Z)-N-[(4E,8E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxydodeca-4,8-dien-2-yl]docosa-10,13,16-trienamide
C52H89NO18 (1015.6079334000001)
(5Z,8Z,11Z,14Z,17Z)-N-[1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxytetradecan-2-yl]icosa-5,8,11,14,17-pentaenamide
C52H89NO18 (1015.6079334000001)
(7Z,10Z,13Z,16Z,19Z)-N-[1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxydodecan-2-yl]docosa-7,10,13,16,19-pentaenamide
C52H89NO18 (1015.6079334000001)
(12Z,15Z,18Z,21Z)-N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]tetracosa-12,15,18,21-tetraenamide
C52H89NO18 (1015.6079334000001)
(10Z,13Z,16Z,19Z)-N-[(E)-1-[5-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxydodec-4-en-2-yl]docosa-10,13,16,19-tetraenamide
C52H89NO18 (1015.6079334000001)
P8RI
P8RI (D-P8RI) is a biomimetic peptide of CD31 and a CD31 agonist. P8RI binds to the juxtamembrane amino acid sequence of the ectodomain of CD31, shows an immunosuppressive effect through restoration of the CD31 inhibitory pathway[1][2].
n-[(1r,2r,3r,4s,5r)-2-{[(2s,3s,4s,7r)-7-[(3r,3as,5ar,5br,7as,10r,11as,11br,13ar,13bs)-5a,5b,8,8,10,11a,13b-heptamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl]-2,3,4-tris(acetyloxy)octyl]oxy}-4,5-bis(acetyloxy)-3-[(acetyloxy)methyl]-3-hydroxycyclopentyl]ethanimidic acid
n-{2-[(7-{5a,5b,8,8,10,11a,13b-heptamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl}-2,3,4-tris(acetyloxy)octyl)oxy]-4,5-bis(acetyloxy)-3-[(acetyloxy)methyl]-3-hydroxycyclopentyl}ethanimidic acid
15,27,30-tribenzyl-17,20,23,26,29,32-hexahydroxy-24-isopropyl-18-methyl-21-(sec-butyl)-1,7,13,16,19,22,25,28,31-nonaazatetracyclo[31.3.0.0³,⁷.0⁹,¹³]hexatriaconta-16,19,22,25,28,31-hexaene-2,8,14-trione
C56H73N9O9 (1015.5530967999999)
n-[(1r,2r,3r,4s,5r)-2-({7-[(3r,3as,5ar,5br,7as,10r,11as,11br,13ar,13bs)-5a,5b,8,8,10,11a,13b-heptamethyl-hexadecahydrocyclopenta[a]chrysen-3-yl]-2,3,4-tris(acetyloxy)octyl}oxy)-4,5-bis(acetyloxy)-3-[(acetyloxy)methyl]-3-hydroxycyclopentyl]ethanimidic acid
(3s,9s,15s,18s,21s,24s,27s,30s,33s)-15,27,30-tribenzyl-21-[(2s)-butan-2-yl]-17,20,23,26,29,32-hexahydroxy-24-isopropyl-18-methyl-1,7,13,16,19,22,25,28,31-nonaazatetracyclo[31.3.0.0³,⁷.0⁹,¹³]hexatriaconta-16,19,22,25,28,31-hexaene-2,8,14-trione
C56H73N9O9 (1015.5530967999999)
(2s)-2-{[(2s)-2-{[(2r)-2-{[(2r)-1,3-dihydroxy-2-({hydroxy[(2s,7r,8r)-6,7,9-trihydroxy-8-[(1-hydroxyoctadecylidene)amino]-3,4,7,8-tetrahydro-2h-1,5-diazonin-2-yl]methylidene}amino)propylidene]amino}-1-hydroxy-5-(n-hydroxyacetamido)pentylidene]amino}-1,3-dihydroxypropylidene]amino}-5-(n-hydroxyacetamido)pentanoic acid
C46H81N9O16 (1015.5800985999999)